Reference

Age& gender

Site

Epithelial component

Mesenchymal component

Outcome

Meeae Y Kwon, et al. [7]

47/ Male

Parotid

Poorly differentiated adenocarcinoma

 SCC

RMS,

Fibrosarcoma

Disease free at 12 months post-surgery

Dimitrios Andreadis, et al. [21]

73/ Male

Parotid

Salivary duct carcinoma

Fibrosarcoma

MFH (UPS)

Osteosarcoma

Not available

Jin Tanahashi, et al. [4]

56/ Male

Submandibular

Poorly differentiated adenocarcinoma

SDC, SCC, UC

Spindle cell sarcoma

Chondrosarcoma

Liposarcoma

RMS

Disease free at 15 months post- surgery

Fedrik Petersson, et al. [17]

50/ Male

Parotid

TTF1- positive LCNEC

Myxofibrosarcoma

Not applicable (recently diagnosed)

Ishikura, et al. [27]

47/ Female

Parotid

UC, adenocarcinoma

Chondrosarcoma, osteosarcoma

Not available

Duan Feng, et al. [8]

76/ Female

Parotid

PDC

Spindle cell sarcoma with small % of osteosarcoma

Disease free at 12 months post- surgery

Yingting Mok, et al. [22]

74/ Male

Parotid

Salivary duct carcinoma

UPS

Disease free at 8 months post- surgery

Tiffany Ng Chao, et al. [28]

83/ Female

Parotid

Poorly differentiated adenocarcinoma

Chondrosarcoma

Lung and liver nodules at 3 years after diagnosis

Shalini Bhalla, et al. [23]

50/ Male

Submandibular

Adenocarcinoma

UPS

Disease free at 12 months post -surgery

Chang Gok Woo C, et al. [10]

72/ Male

Parotid

SCC, adenocarcinoma

Osteosarcoma

Abdominal metastasis at 6 months post – surgery

Yoko Endo, et al. [5]

64/ Male

Submandibular

Adenocarcinoma

Osteosarcoma

Lung metastasis at 4 months post – surgery

Ali A Almubarak, et al. [6]

75/ Male

Parotid

SCC

Chondrosarcoma

Not available

Present study

(i)58/ Male

(ii)32/ Female

Parotid

Parotid

Myoepithelial carcinoma

Salivary Duct carcinoma

Osteosarcoma

UPS

Locoregional recurrence at 2 months post – surgery and died 6 months after.

Expired at 8 months post - surgery